Prihlásiť sa Zaregistrujte sa zadarmo

Cena / účtovná hodnotae spoločnosti Adma Biologics Inc

Aká je hodnota metriky Cena / účtovná hodnotae spoločnosti Adma Biologics Inc?

Hodnota metriky Cena / účtovná hodnotae spoločnosti Adma Biologics Inc je 5.16

Aká je definícia metriky Cena / účtovná hodnotae?



Cena / učtovná hodnota (Price to book ratio) ukazateľ vyjadruje pomer medzi hodnotou spoločnosti a book value spoločnosti, čo je hodnota čistých aktív.

The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).

The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).

P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.

Cena / účtovná hodnotae spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Adma Biologics Inc

Čomu sa venuje spoločnosť Adma Biologics Inc?

adma is a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the treatment and prevention of primary immune deficiency disease (pidd) and certain infectious diseases. adma's mission is to develop and commercialize plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases. the target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease, or who may be immune-compromised for medical reasons. adma’s lead product candidate, ri-002, has completed a phase iii clinical trial in patients with pidd and has met the primary endpoint. a bla for ri-002 was accepted by the fda on september 18, 2015. the company has received u.s. patent 9,107,906. for more information, please visit the company's website at www.admabiologics.com.

Firmy s metrikou cena / účtovná hodnotae podobnou spoločnosti Adma Biologics Inc



  • Hodnota metriky Cena / účtovná hodnotae spoločnosti Fleetcor Techs Dl ,001 je 5.15
  • Hodnota metriky Cena / účtovná hodnotae spoločnosti MTS Systems je 5.15
  • Hodnota metriky Cena / účtovná hodnotae spoločnosti Streamline Health Solutions, Inc je 5.15
  • Hodnota metriky Cena / účtovná hodnotae spoločnosti Lifestyle Communities je 5.15
  • Hodnota metriky Cena / účtovná hodnotae spoločnosti Onoff AG je 5.15
  • Hodnota metriky Cena / účtovná hodnotae spoločnosti Pushpay je 5.15
  • Hodnota metriky Cena / účtovná hodnotae spoločnosti Adma Biologics Inc je 5.16
  • Hodnota metriky Cena / účtovná hodnotae spoločnosti Tata Motors je 5.16
  • Hodnota metriky Cena / účtovná hodnotae spoločnosti Spark New Zealand je 5.16
  • Hodnota metriky Cena / účtovná hodnotae spoločnosti KBR Inc je 5.16
  • Hodnota metriky Cena / účtovná hodnotae spoločnosti ImmunoPrecise Antibodies je 5.17
  • Hodnota metriky Cena / účtovná hodnotae spoločnosti S.P. Apparels je 5.17
  • Hodnota metriky Cena / účtovná hodnotae spoločnosti First Sensor AG je 5.17